The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Explore this paper's citation graph
- Type
- letter
- Published
- 1994-03-31
- Cited by
- 1,904
- References
- 0
- OpenAlex
- https://openalex.org/W2319268509
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8035430
Keywords
Captopril, Medicine, Diabetic nephropathy, Creatinine, Diabetes mellitus
References
No references recorded for this paper.
Cited by
- Prevention of Macrovascular Disease: Absolute Proof or Absolute Risk?
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
- Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients
- Pharmacological treatment of diabetic patients with cardiovascular complications
- Use of Angiotensin-Converting Enzyme Inhibitors in Patients with Diabetic and Nondiabetic Chronic Renal Diseases: A Need for Reassessment
- Differences in Renal Outcomes with ACE Inhibitors in Type 1 and Type 2 Diabetic Patients: Possible Explanations
- Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas
- Prospective evaluation of autonomic dysfunction in aggressive management of diabetic microangiopathy.
- A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
- Renal graft failure after addition of an angiotensin II receptor antagonist to an angiotensin-converting enzyme inhibitor: unmasking of an unknown iliac artery stenosis
- Treatment of Lupus Nephritis
- ACE-I and ARBs in early diabetic nephropathy
- Markov Modeling Analysis of Health and Economic Outcomes of Therapy With Valsartan Versus Amlodipine in Patients With Type 2 Diabetes and Microalbuminuria
- Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent
- Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis
- Caring for Patients with Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy
- Agents in development for the treatment of diabetic nephropathy
- Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes
- Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
- Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis
Related papers
- Angiotensin I-converting enzyme and angiotensin II levels in women receiving an oral contraceptive.
- ABNORMALITY OF THE GLOMERULAR ANGIOTENSIN II RECEPTOR IN EXPERIMENTAL DIABETIC NEPHROPATHY
- Effect of the circulating renin-angiotensin system on prolactin release in humans.
- The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat.
- Sex-specific modulation of blood pressure and the renin angiotensin system by angiotensin converting enzyme 2
- Angiotensin II Type II Receptor Deficiency Accelerates the Development of Nephropathy in Type I Diabetes via Oxidative Stress and ACE2
- Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage?
- Impact of Diabetes on ACE/ACE2 Balance and Angiotensin II Type 1 Receptor Expression in db/db Diabetic Mice
- Angiotensin Converting Enzyme (ACE) and Angiotensinogen (AGT) Gene Variants in Pakistani Patients of Diabetes Mellitus and Diabetic Nephropathy
- Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.